Table 4.

Between-group comparison of rCBF levels at different time-points.

Groups	Cases	Before modeling (PU)	After modeling (PU)	After 4 weeks of injection (PU)
Saline	8	616.54±14.12	243.84±24.74	244.62±25.16
pVAX1	8	617.22±15.21	245.15±25.02	245.54±25.24
pVAX1-ADM (low-dose)	8	614.61±16.74	247.01±25.42	378.54±28.83*
pVAX1-ADM (mid-dose)	8	615.91±16.30	246.14±25.25	491.26±30.55*,#
pVAX1-ADMg (high-dose)	8	619.04±17.11	248.07±25.64	582.43±31.64*,#,@

Comparison with the saline group and pVAX group,

^*P<0.05; comparison with the pVAX1-ADM low-dose group,

^#P<0.05; comparison with the pVAX1-ADM mid-dose group,

^@P<0.05.